ArticleCancer chemotherapy and pharmacology2019

Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias.

Renu Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.